Divergent role of ceramide generated by exogenous sphingomyelinases on NF-κB activation and apoptosis in human colon HT-29 cells  by Colell, Anna et al.
Divergent role of ceramide generated by exogenous sphingomyelinases on
NF-UB activation and apoptosis in human colon HT-29 cells
Anna Colella, Olga Colla, Montse Mar|¤a, Jose¤ C. Ferna¤ndez-Checaa;b;, Carmen Garc|¤a-Ruiza
aLiver Unit, Instituto de Malalties Digestives, Hospital Clinic i Provincial, Instituto Investigaciones Biome¤dicas August Pi Sun‹er,
C/Villarroel 170, Barcelona 08036, Spain
bDepartment of Experimental Pathology, Instituto Investigaciones Biome¤dicas Barcelona, Consejo Superior de Investigaciones Cient|¤¢cas,
Barcelona 08036, Spain
Received 4 June 2002; revised 13 July 2002; accepted 15 July 2002
First published online 30 July 2002
Edited by Guido Tettamanti
Abstract This study examined the role of ceramide generated
by exogenous sphingomyelinases (SMases) on transcription nu-
clear factor-UB (NF-UB) activation and apoptosis in human co-
lon epithelial HT-29 cells. Exogenous neutral (N) and acidic (A)
SMase activated NF-UB with di¡erent kinetics, accounting for
the diverse pattern of DNA binding of NF-UB complexes acti-
vated by tumor necrosis factor-K (TNF). NSMase activated
predominantly RelA/p52 and RelA/p50 dimers within 30 min,
while ASMase activated the p50/p50 homodimer by 20 h. The
predominant activation of RelA-containing UB complexes by
TNF or NSMase paralleled the induction of interleukin-8.
HT-29 cells were sensitive to ASMase and TNF but resistant
to NSMase. However, the apoptotic potential of NSMase was
masked by NF-UB, as its prior inactivation sensitized HT-29
cells to NSMase. Thus, the generation of ceramide by exoge-
nous SMases participates di¡erentially in in£ammation and
apoptosis. 2 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
Key words: Ceramide; Sphingomyelinase; Apoptosis;
Transcription nuclear factor-UB
1. Introduction
Tumor necrosis factor-K (TNF) triggers diverse signaling
pathways that account for divergent cellular responses such
as in£ammation or apoptosis. TNF-induced apoptosis is
mediated by its binding to TNF plasma membrane receptor-
1 (TNFR-1), causing receptor oligomerization and subsequent
recruitment of the TNFR-associated adapter protein with
death domain (TRADD) [1^4]. The binding of TRADD to
Fas-associated protein with death domain (FADD) [5,6] acti-
vates caspase-8, which, in turn, cuts speci¢c target proteins
including pro-caspase-3 [7^9]. Furthermore, the binding of
TRADD to the downstream transducer protein TNFR-asso-
ciated factor-2 and the transcription nuclear factor-UB (NF-
UB)-inducing kinase results in the activation of NF-UB, which
activates the transcription of antiapoptotic genes that antag-
onize the FADD-mediated death signals [10^12]. NF-UB is
usually kept inactive in the cytoplasm through association
with an endogenous inhibitor protein of the NF-UB (IUB)
family. The activation of NF-UB by TNF involves the phos-
phorylation of IUB targeting its subsequent degradation by
the proteasome. The released subunits of NF-UB translocate
to the nuclei where they bind to consensus binding sites in the
promoter/enhancer region of target genes.
Ceramide is a sphingolipid increasingly recognized as an
important mediator of signal transduction processes leading
to a variety of cellular responses, including apoptosis [13,14].
Ceramide in cells can arise by several mechanisms [15]. In
addition to the de novo ceramide synthesis through serine-
palmitoyl transferase and ceramide synthase, the levels of
this lipid can increase by the action of sphingomyelinase
(SMase). SMase is a principal enzyme catalyzing the hydroly-
sis of sphingomyelin to ceramide and phosphocholine. Out of
the various SMases described, two types of SMases in mam-
malian cells are of particular relevance in signaling pathways;
neutral SMase with an optimum pH at around 7.5, membrane
bound and Mg2þ-dependent, and acidic SMase with an opti-
mum pH at around 4.8, further subclassi¢ed to two isoforms,
an endosomal/lysosomal acidic SMase and a secretory Zn2þ-
dependent SMase [16^18]. Indeed, TNF activates neutral and
acidic SMase activities [13^16], indicating the ability of TNF
to generate ceramide at di¡erent intracellular locations, sug-
gesting the potential involvement of ceramide in distinct sig-
naling pathways.
A common strategy used to assess the role of endogenous
ceramide on cellular responses has been the use of exogenous
SMases. The Mg2þ-dependent, neutral pH optimum bacterial
SMase from Bacillus cereus (NSMase) has been widely used to
examine the role of ceramide on gene regulation, in£amma-
tion and apoptosis in a variety of cell types [19^25]. The acidic
human placenta SMase (ASMase) is an acidic pH optimum
SMase, which has been shown to enter cells via endocytosis
becoming active in acidic compartments [22,26,27]. Consistent
with these features, mannose 6-phosphate and pH gradient-
collapsing agents, e.g. monensin, have been reported to pre-
vent the e¡ects of this enzyme on reactive oxygen species
generation, caspase activation and apoptosis [26,27].
Thus, the purpose of our work was to examine the role of
ceramide generated by exogenous SMases on NF-UB activa-
tion and apoptosis in human HT-29 cells. We provide evi-
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dence that NSMase induces interleukin-8 (IL-8) expression
and that its apoptotic potential is counteracted by RelA-con-
taining UB members activated by NSMase. In contrast, HT-29
cells exhibit intrinsic sensitivity to ASMase accompanied by
the predominant activation of p50/p50.
2. Materials and methods
2.1. Cell culture and experimental conditions
The human colon cancer cell line HT29 was purchased from the
European Collection of Animal Cell Cultures (Salisbury, UK). HT-29
cells were cultured in Dulbecco’s modi¢ed Eagle’s medium containing
25 mM glucose in the presence of 100 U/ml penicillin, 100 Wg/ml
streptomycin and 10% heat-inactivated fetal bovine serum. Cells
(5U105 cells/ml) were seeded into 6-well plates and con£uent cell
monolayers were then incubated for various periods of time with
human recombinant TNF (Promega, 14^280 ng/ml), B. cereus
NSMase or human placenta ASMase (0.1^0.5 U/ml) or appropriate
vehicle as described previously [22,27]. In some cases, cells were pre-
treated with Bay 11-7085 before exposure to TNF or exogenous
SMases. To examine whether the various treatments induced HT-29
di¡erentiation, we analyzed the release of carcinoembryogenic antigen
(CEA). After cell treatment with TNF, NSMase or ASMase, culture
media was collected and centrifuged (10 min, 2000Ug). The level of
CEA in the supernatants was determined by the Abbott CEA-EAI
monoclonal One-Step kit and normalized to the number of attached
cells. Under the experimental conditions used the level of CEA varied
from 5 to 7 ng/mg protein and did not change by the various treat-
ments.
2.2. Determination of NSMase and ASMase activities
Mg2þ-dependent NSMase as well as ASMase activity were deter-
mined by monitoring [N-methyl-14C]sphingomyelin (56.6 mCi/mmol)
hydrolysis as described before [16,27]. SMase activities were deter-
mined from cell extracts prepared after TNF treatment as described
[16]. Brie£y, following TNF treatment HT-29, cells were immersed in
a methanol^dry ice bath. Cells were scraped, spun (800Ug) for 5 min
at 4‡C and washed two times with phosphate-bu¡ered saline. To mea-
sure NSMase, cell pellets were dissolved in a bu¡er containing 20 mM
HEPES, pH 7.4, 10 mM MgCl2, 2 mM EDTA, 5 mM dithiothreitol
(DTT), 0.1 mM Na3VO4, 0.1 mM Na2MoO4, 30 mM p-nitrophenyl-
phosphate, 10 mM L-glycerophosphate, 750 WM ATP, 1 mM phenyl-
methylsulfonyl £uoride (PMSF), 10 mM leupeptin, 10 WM pepstatin
and 0.2% Triton X-100. After incubation for 5 min at 4‡C, cells were
homogenized by repeatedly squeezing the cells through an 18-gauge
needle. Nuclei and cell debris were removed by low speed centrifuga-
tion (800Ug). Supernatants (30^50 Wg protein) were incubated for 2 h
at 37‡C in a bu¡er containing 20 mM HEPES, 1 mM MgCl2 (pH 7.4)
and 2.25 Wl [N-methyl-14C]sphingomyelin. To measure ASMase, cell
pellets were resuspended in 200 Wl of 0.2% Triton X-100 and incuba-
ted for 15 min at 4‡C followed by centrifugation in a microfuge at
14 000 rpm for 10 min at 4‡C. Supernatants (30^50 Wg protein) were
incubated for 2 h at 37‡C in a bu¡er (50 Wl ¢nal volume) containing
250 mM sodium acetate, 1 mM EDTA (pH 5.0) and 2.25 Wl of
[N-methyl-14C]sphingomyelin. Phosphorylcholine was extracted with
800 Wl chloroform:methanol (2:1, v/v) and 250 Wl water and identi¢ed
by thin-layer chromatography and routinely determined by scintilla-
tion counting.
2.3. Measurement of ceramide
Cellular lipids after treatment with TNF, NSMase and ASMase
were extracted in chloroform:methanol (1:1, v/v). Ceramide levels
were determined by the diacylglycerol kinase assay in TLC plates
developed in chloroform:acetic acid (9:1, v/v) or high-performance
liquid chromatography (HPLC) after derivatization of the sphingoid
base with o-phthalaldehyde following deacylation of ceramide as char-
acterized previously [27].
2.4. Electrophoretic mobility shift assays
Activation of NF-UB was examined using consensus oligonucleotide
UB probe labeled by T4 polynucleotide kinase using nuclear extracts
as described before [28]. Cells were washed twice with ice-cold phos-
phate-bu¡ered saline and collected with a rubber policeman after the
various treatments. Cells were resuspended in 10 mM HEPES, pH 7.8,
containing 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT,
and 0.5 mM PMSF, 10 Wg/ml leupeptin, 10 Wg/ml aprotinin, and 10 Wg/
ml TLCK and kept on ice for 15 min. Cells were then lysed with
Nonidet P-40 (10%), and the nuclear pellet was recovered after cen-
trifugation at 13 000Ug at 4‡C for 30 s. The nuclear pellet was re-
suspended in ice-cold 20 mM HEPES, pH 7.4, containing 0.4 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF, 10 Wg/
ml leupeptin, 10 Wg/ml aprotinin, and 10 Wg/ml TLCK and stored at
80‡C. Supershift assays were done using human antibodies anti-RelA
(p65), p50, p52, c-Rel and RelB as described previously [28].
2.5. IL-8 expression
Total cellular RNA was isolated using the Trizol reagent (Life
Technologies, Barcelona, Spain). A cDNA probe for IL-8 was gener-
ated by polymerase chain reaction using the following primers
5P(+1584^1603)-ATGATCTCCAAGCTGGCCG-3P and 5P(32877^
2896)-GTCTCTCTTCCATCATCAGAAAGC-5P, designed from the
genomic sequence of IL-8 (GenBank accession number M28130).
The 226-bp cDNA fragment was cloned into pGemT (Promega, Mad-
ison, WI, USA) and sequenced. Twenty Wg total RNA was fraction-
ated in a 1% agarose gel under denaturing conditions and transferred
on nylon membrane, ¢xed by baking at 80‡C for 2 h. The membranes
were prehybridized at 65‡C and hybridizations were performed using
the Random Prime II labeling system (Amersham). RNA levels were
calculated relative to the 18S used as internal reference control and
expressed as percentage of control. Densitometric quantitation of
autoradiographs was performed with a densitometer Preference
(Seba, France).
2.6. Determination of cell death and apoptosis
Cell survival was quantitated by measurement of lactate dehydro-
genase (LDH) in culture supernatants and in the remaining cell mono-
layer after lysis with 0.1% Triton X-100, expressing the percentage of
LDH release in the medium as the fraction of total LDH (medium
plus cells) as described [29]. Alternatively, cell viability was ascer-
tained by the MTT assay adding MTT (20 Wl of 5 mg/ml MTT in
phosphate-bu¡ered saline) and the absorbance was measured at
570 nm [30]. Apoptotic features of cell death were determined by
staining of the cells with the DNA binding £uorochrome H33258
assessing chromatin condensation by £uorescence microscope analyses
or nuclear DNA fragmentation by gel electrophoresis as described
previously [29,31].
2.7. Statistics analyses
Results are expressed as the meanTS.D. and are averages of three
to ¢ve values per experiment. Di¡erences between treatments were
compared using an analysis of variance for repeated measures and
statistical analyses of mean values for multiple comparisons were
made by one-way analysis of variance.
3. Results
3.1. Activation of NF-UB by exogenous SMases
Since SMases can generate ceramide from the hydrolysis of
sphingomyelin, we ¢rst determined the level of ceramide gen-
erated upon treatment of HT-29 cells with exogenous NSMase
and ASMase. Exogenous NSMase and ASMase increased cer-
amide levels in a time-dependent manner, peaking at 1^2 h
and declining thereafter to basal levels (Fig. 1). The magni-
tude of ceramide generation increased with increasing dose of
exogenous SMases. Likewise, TNF stimulated an early ceram-
ide generation between 1 and 2 h, the magnitude of which was
dependent on the dose of TNF; however, unlike exogenous
SMases, the stimulated ceramide generation by TNF was
more sustained remaining above control levels by 10 h post
incubation (Fig. 1).
Moreover, since activation of NF-UB is a prominent e¡ect
of TNF, we next analyzed the activation of NF-UB by exog-
enous SMases. The DNA binding activity of NF-UB revealed
the presence of several complexes, denoted by the arrows, that
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Fig. 1. Ceramide levels generated by TNF or exogenous SMases. A: HT-29 cells were exposed to TNF (14 ng/ml), NSMase or ASMase
(0.1 U/ml) for the indicated periods of time. B: As A except that cells were incubated with 280 ng/ml of TNF or 0.5 U/ml of NSMase and
ASMase. Lipid extracts were isolated and ceramide determined by HPLC. Control ceramide levels were 1.8 T 0.3 nmol/mg protein. Triangles,
TNF; squares, NSMase; circles, ASMase. Results are the meanTS.D. of ¢ve independent experiments.
Fig. 2. Activation of NF-UB by TNF and exogenous SMases. HT-29 cells were incubated with either TNF (280 ng/ml) (A) or exogenous
NSMase or ASMase (0.5 U/ml, each) (B) for the indicated periods of time and nuclear extracts were assayed for UB DNA binding. Representa-
tive experiment out of ¢ve independent ones giving similar results is shown. The magnitude of activation of the individual UB complexes was
estimated by densitometry. The quantitation of UB complexes is expressed as the meanTS.D. of ¢ve independent experiments. The variability
between individual experiments was below 13%; *P6 0.05 vs. control.
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were activated by TNF at di¡erent time points (Fig. 2A). As
revealed by the supershift assays, there were three complexes,
RelA/p52, RelA/p50 and p50/p50, all of which were displaced
by unlabeled oligonucleotide (Fig. 3). The DNA binding ac-
tivity of the two upper bands, corresponding to RelA/p52 and
RelA/p50 heterodimers, increased by 30 min post treatment
and declined over time; however, the lower band, correspond-
ing to p50/p50 homodimer, increased gradually over time
from 4 to 20 h (Fig. 2A).
NSMase enhanced the DNA binding of RelA/p52 and
RelA/p50 at 30 min post incubation (Fig. 2B). The activation
of these complexes were maintained for up to 4 h (not shown)
and declined at 20 h post treatment (Fig. 2B). However, in
contrast to TNF, there was no evidence for the activation of
p50/p50 homodimer by NSMase (Fig. 2B). In contrast to this
pattern, the predominant UB complex activated by ASMase
was the p50/p50 homodimer whose activation was detectable
by 12 h post treatment (not shown); at 20 h after TNF treat-
ment the p50 homodimer was the only active complex de-
tected (Fig. 2B). Unlike NSMase, there was no evidence for
RelA-containing UB members by ASMase (Fig. 2B). Thus,
these data show that exogenous NSMase and ASMase acti-
vated distinct UB complexes.
3.2. IL-8 induction by exogenous SMases
Since NF-UB plays a key role as a pro-in£ammatory tran-
scription factor by stimulating the synthesis of in£ammatory
cytokines [32,33], we next examined the expression of IL-8 in
HT-29 cells following NSMase and ASMase treatment.
Northern blot analyses indicated that TNF induced a strong
expression of IL-8 (640T 42% over control, n=4, P6 0.005)
(Fig. 4). NSMase induced the levels of IL-8 mRNA by 4 h
(356T 44% over control, n=4, P6 0.005), and ASMase in-
duced a weaker IL-8 expression (152T 34% over control at
24 h post incubation, n=4, P6 0.05) (Fig. 4).
3.3. Divergence of NSMase and ASMase in the induction of
apoptosis
To determine whether ceramide generated by exogenous
SMases participates in the cytotoxic e¡ects of TNF, we next
examined the apoptotic potential of either SMase compared
to that of TNF. TNF induced a dose-dependent loss of via-
bility, which was signi¢cant at 24 or 12 h post incubation at
14 ng/ml or 280 ng/ml, respectively (P6 0.05) (Fig. 5A). This
form of cell death was accompanied by disruption of chroma-
tin integrity, indicative of apoptosis (not shown). In contrast,
NSMase failed to kill HT-29 cells at either of the doses exam-
ined (Fig. 5). On the other hand, ASMase mimicked the cy-
totoxic e¡ect of TNF, being signi¢cant at 48 or 12 h of in-
cubation with 0.1 U/ml or 0.5 U/ml, respectively (P6 0.05)
(Fig. 5). The apoptotic potential of ASMase was prevented by
mannose 6-phosphate and monensin through competition
with the mannose 6-phosphate receptor [34] and pH gradient
collapse in acidic compartments [26,27] (not shown).
3.4. NF-UB activation unmasks the apoptotic potential of
NSMase
To examine if the inability of NSMase to induce apoptosis
was masked by the activation of survival pathways dependent
on NF-UB, we pretreated cells with agents that block NF-UB
activation before incubation with NSMase. Bay 11-7085 has
been shown to suppress NF-UB activation by interfering with
Fig. 3. Supershift assay of active UB complexes. Nuclear extracts
from HT-29 cells after TNF exposure (280 ng/ml for 2 h) were incu-
bated with di¡erent antibodies against di¡erent members of UB as
indicated. In addition, nuclear extracts were exposed to a molar ex-
cess of unlabeled UB oligonucleotide to check for speci¢city of the
di¡erent UB complexes. Representative experiment out of ¢ve inde-
pendent ones giving similar results.
Fig. 4. IL-8 mRNA level in response to exogenous SMases. HT-29
cells were treated with either NSMase or ASMase (0.5 U/ml) for
the indicated periods of time or TNF (280 ng/ml, for 12 h) and the
IL-8 mRNA expression was quantitated relative to the expression of
18S as reference control. Northern blot representative of four di¡er-
ent experiments yielding similar results.
Fig. 5. Time-dependent viability of HT-29 cells following TNF or
exogenous SMases incubation. HT-29 cells were exposed to either
TNF (triangles), NSMase (squares) or ASMase (circles) at the indi-
cated doses for di¡erent periods of time and cell viability was ascer-
tained by LDH release into the medium and expressed as percent-
age of total LDH found in cells plus medium. Results are the
meanTS.D. of ¢ve independent experiments.
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the IUBK phosphorylation [35]. Consistent with this mecha-
nism of action, pretreatment of HT-29 cells with Bay 11-7085
suppressed NF-UB activation induced by NSMase (Fig. 6A).
To examine whether NF-UB inactivation sensitized HT-29
cells to NSMase, we next determined the e¡ect of Bay 11-
7085 on cell survival. This strategy unmasked the apoptotic
potential of NSMase as shown by the progressive loss of cell
viability (Fig. 6B). This form of cell death was apoptotic as
veri¢ed by chromatin disruption (not shown). Taken together
these ¢ndings reveal the importance of NF-UB activation in
controlling the survival of HT-29 cells to NSMase exposure.
4. Discussion
This study examined the role of ceramide generated by
exogenous SMases on NF-UB activation and apoptosis in hu-
man colon epithelial HT-29 cells. Our data reveal that exog-
enous NSMase mimicked the ability of TNF to activate NF-
UB. Both stimuli enhanced the DNA binding activity of RelA/
p52 and RelA/p50 heterodimers, con¢rming previous results
in human gastric epithelial cells [21]. Consistent with the role
of NF-UB activation in gene regulation, we show the inducible
expression of pro-in£ammatory chemokine IL-8 in response
to TNF and NSMase. The transcriptional expression of IL-8
has been shown to require the combination of several tran-
scription factors, including NF-UB and AP-1 or NF-UB and
NF-IL6, as reported for di¡erent cell types [36^38]. It is con-
ceivable that the recruitment and activation of these combi-
nations may account for the greater transcriptional expression
of IL-8 by TNF compared to NSMase.
An intriguing ¢nding of our study is that exogenous
NSMase did not signal cell death. Indeed, this resistance of
HT-29 cells to exogenous bacterial NSMase con¢rms previous
reports [19,21], although these studies did not address the
activation of NF-UB by NSMase. In pursuing this issue fur-
ther, we examined whether NF-UB activation may have pro-
tected HT-29 cells against NSMase-induced apoptosis, as it is
known that NF-UB induces the expression of antiapoptotic
genes. To this end, cells were pretreated with Bay 11-7085
that interferes with IUBK phosphorylation, thus preventing
the proteasome-stimulated hydrolysis of IUB. Since IUB se-
questers NF-UB inactive in the cytosol, this agent abolishes
the nuclear translocation of active UB members. As con¢rmed
by electrophoretic mobility shift assays, Bay 11-7085 blocked
the activation of NF-UB induced by NSMase. Indeed, using
this approach we show that Bay 11-7085 renders HT-29 cells
sensitive to exogenous NSMase treatment, thus unmasking
the apoptotic potential of exogenous NSMase. Previous stud-
ies indicated a di¡erential apoptotic outcome of treating
Molt-4 cells with exogenous NSMase vs. its transfection, de-
spite that both strategies generated similar ceramide levels
[20]. These ¢ndings promoted the concept of the existence
of an apoptotic ceramide pool whose ability to signal cell
death appears to depend on the cellular location within the
plasma membrane where ceramide is generated by bacterial
NSMase [20]. In contrast to this view, we provide evidence
that the exogenous bacterial NSMase-induced ceramide gen-
eration has the potential to signal apoptotic cell death in HT-
29 cells. However, the impact of this process is counteracted
by the induction of survival genes dependent on NF-UB acti-
vation, and, hence our data show that the pool of ceramide
generated by NSMase is linked to both NF-UB and apoptotic
pathways.
Our data indicate the activation of NF-UB in response to
exogenous ASMase. Compared to exogenous NSMase, this
process was a late event resulting in the predominant activa-
tion of the homodimer p50/p50. Although we have not ad-
dressed the signaling events leading to the selective activation
of p50/p50 by ASMase, inhibitors of IUBK phosphorylation
prevented the activation of p50/p50 by ASMase. Hence, it is
conceivable that ASMase may activate the IUB kinase com-
plex, which in turn leads to phosphorylation and proteasome-
limited proteolysis of p105, the precursor form of p50 [39].
Further work will be required to discern whether ASMase
activates the kinase complex or inhibits a cellular phospha-
tase.
The pattern of gene induction by p50/p50 homodimer may
di¡er from that induced by RelA-containing heterodimers.
While RelA/p52 can induce the expression of survival genes
[10^12,21], p50/p50 homodimer has been reported to signal
the repression of pro-in£ammatory gene transcription, which
may play a role in the resolution of in£ammation [40]. In
addition, a role has been suggested of p50/p50 in the expres-
Fig. 6. Inactivation of NF-UB and apoptosis induced by NSMase.
HT-29 cells were pretreated with Bay 11-7085 (20 WM) before incu-
bation with NSMase (0.5 U/ml) for 2 h, and nuclear extracts were
used for NF-UB activation (A). Parallel culture plates were treated
with NSMase for various periods of time in the absence or presence
of Bay 11-7083 and cell survival was determined by LDH release
into the medium (B). Results are the meanTS.D. of four individual
experiments. *P6 0.05 vs. control.
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sion of pro-apoptotic p53 and Bax involved in the apoptosis
of leukocytes [40]. However, the sensitivity of HT-29 cells to
exogenous ASMase was unaltered when the activation of this
predominant UB complex activated by ASMase (p50/p50 ho-
modimer) was prevented. These ¢ndings suggest that the p50/
p50 homodimer is not directly involved in the generation of
death signals.
Overall, to the best of our knowledge this is the ¢rst report
analyzing the e¡ects of diverse exogenous SMases in the reg-
ulation of NF-UB activation and apoptosis in human colon
epithelial cells. Our ¢ndings suggest the intriguing possibility
that the fate of endogenous ceramide generated by the action
of exogenous NSMase or ASMase in activating distinct NF-
UB complexes resulting or not in apoptosis seems to depend
on the cellular site where ceramide is released.
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